Fig. 3From: Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot studyMonocyte myeloid-derived suppressor cells kinetics. Monocyte myeloid-derived suppressor cells (M-MDSC) kinetics from admission to day 8–10 in patients with secondary infection (a) or survivors at day 28 (b). **p < 0.005Back to article page